Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

83.91
Delayed Data
As of Sep 22
 +0.58 / +0.70%
Today’s Change
64.18
Today|||52-Week Range
86.72
+14.09%
Year-to-Date
Oramed Now Has a Clear Path to Market With Oral Insulin
Sep 22 / GuruFocus News - Paid Partner Content
AbbVie's RA Candidate Meets Primary Endpoint in Phase III
Sep 12 / Zacks.com - Paid Partner Content
Lilly/Incyte's Baricitinib Meets Endpoint in Eczema Study
Sep 15 / Zacks.com - Paid Partner Content
Eli Lilly cuts 3,500 jobs as focus turns to costs
Sep 07 / FT.com - Paid Partner Content
Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO
Sep 15 / Zacks.com - Paid Partner Content
RH surges as group transformation is hailed
Sep 07 / FT.com - Paid Partner Content
4 Biotech Stocks That Show Promise on Sustainable Growth
Sep 14 / Zacks.com - Paid Partner Content
Google parent backs machine-learning cancer treatment
Sep 07 / FT.com - Paid Partner Content
Array's NDAs for Melanoma Combo Accepted for Review by FDA
Sep 13 / Zacks.com - Paid Partner Content